Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Oct;8(4):462–478. doi: 10.1128/cmr.8.4.462

New and emerging yeast pathogens.

K C Hazen 1
PMCID: PMC172871  PMID: 8665465

Abstract

The most common yeast species that act as agents of human disease are Candida albicans, Candida tropicalis, Candida glabrata, Candida parapsilosis, and Cryptococcus neoformans. The incidence of infections by other yeasts has increased during the past decade. The most evident emerging pathogens are Malassezia furfur, Trichosporon beigelii, Rhodotorula species, Hansenula anomala, Candida lusitaniae, and Candida krusei. Organisms once considered environmental contaminants or only industrially important, such as Candida utilis and Candida lipolytica, have now been implicated as agents of fungemia, onychomycosis, and systemic disease. The unusual yeasts primarily infect immunocompromised patients, newborns, and the elderly. The role of central venous catheter removal and antifungal therapy in patient management is controversial. The antibiograms of the unusual yeasts range from resistant to the most recent azoles and amphotericin B to highly susceptible to all antifungal agents. Current routine methods for yeast identification may be insufficient to identify the unusual yeasts within 2 days after isolation. The recognition of unusual yeasts as agents of sometimes life-threatening infection and their unpredictable antifungal susceptibilities increase the burden on the clinical mycology laboratory to pursue complete species identification and MIC determinations. Given the current and evolving medical practices for management of seriously ill patients, further evaluations of the clinically important data about these yeasts are needed.

Full Text

The Full Text of this article is available as a PDF (783.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahearn D. G., McGlohn M. S. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole. J Clin Microbiol. 1984 Mar;19(3):412–416. doi: 10.1128/jcm.19.3.412-416.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Al-Hedaithy S. S. The medically important yeasts present in clinical specimens. Ann Saudi Med. 1992 Jan;12(1):57–62. doi: 10.5144/0256-4947.1992.57. [DOI] [PubMed] [Google Scholar]
  3. Alsina A., Mason M., Uphoff R. A., Riggsby W. S., Becker J. M., Murphy D. Catheter-associated Candida utilis fungemia in a patient with acquired immunodeficiency syndrome: species verification with a molecular probe. J Clin Microbiol. 1988 Apr;26(4):621–624. doi: 10.1128/jcm.26.4.621-624.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alter S. J., Farley J. Development of Hansenula anomala infection in a child receiving fluconazole therapy. Pediatr Infect Dis J. 1994 Feb;13(2):158–159. doi: 10.1097/00006454-199402000-00018. [DOI] [PubMed] [Google Scholar]
  5. Anaissie E., Bodey G. P., Kantarjian H., Ro J., Vartivarian S. E., Hopfer R., Hoy J., Rolston K. New spectrum of fungal infections in patients with cancer. Rev Infect Dis. 1989 May-Jun;11(3):369–378. doi: 10.1093/clinids/11.3.369. [DOI] [PubMed] [Google Scholar]
  6. Anaissie E., Bodey G. P. Nosocomial fungal infections. Old problems and new challenges. Infect Dis Clin North Am. 1989 Dec;3(4):867–882. [PubMed] [Google Scholar]
  7. Anaissie E., Gokaslan A., Hachem R., Rubin R., Griffin G., Robinson R., Sobel J., Bodey G. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis. 1992 Nov;15(5):781–787. doi: 10.1093/clind/15.5.781. [DOI] [PubMed] [Google Scholar]
  8. Anaissie E., Hachem R., K-Tin-U C., Stephens L. C., Bodey G. P. Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity. Infect Immun. 1993 Apr;61(4):1268–1271. doi: 10.1128/iai.61.4.1268-1271.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Anaissie E., Pinczowski H. Invasive candidiasis during granulocytopenia. Recent Results Cancer Res. 1993;132:137–145. doi: 10.1007/978-3-642-84899-5_14. [DOI] [PubMed] [Google Scholar]
  10. Arisoy E. S., Correa A., Seilheimer D. K., Kaplan S. L. Candida rugosa central venous catheter infection in a child. Pediatr Infect Dis J. 1993 Nov;12(11):961–963. [PubMed] [Google Scholar]
  11. Badenhorst L., Botha P. L., van Rensburg M. N. The incidence of hospital fungal infections--yeast fungaemia. S Afr Med J. 1991 Mar 16;79(6):302–303. [PubMed] [Google Scholar]
  12. Baker J. G., Nadler H. L., Forgacs P., Kurtz S. R. Candida lusitaniae: a new opportunistic pathogen of the urinary tract. Diagn Microbiol Infect Dis. 1984 Apr;2(2):145–149. doi: 10.1016/0732-8893(84)90010-5. [DOI] [PubMed] [Google Scholar]
  13. Banerjee S. N., Emori T. G., Culver D. H., Gaynes R. P., Jarvis W. R., Horan T., Edwards J. R., Tolson J., Henderson T., Martone W. J. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med. 1991 Sep 16;91(3B):86S–89S. doi: 10.1016/0002-9343(91)90349-3. [DOI] [PubMed] [Google Scholar]
  14. Beck-Sagué C., Jarvis W. R. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993 May;167(5):1247–1251. doi: 10.1093/infdis/167.5.1247. [DOI] [PubMed] [Google Scholar]
  15. Bergman A. G., Kauffman C. A. Dermatitis due to Sporobolomyces infection. Arch Dermatol. 1984 Aug;120(8):1059–1060. [PubMed] [Google Scholar]
  16. Bisbe J., Vilardell J., Valls M., Moreno A., Brancos M., Andreu J. Transient fungemia and Candida arthritis due to Candida zeylanoides. Eur J Clin Microbiol. 1987 Dec;6(6):668–669. doi: 10.1007/BF02013067. [DOI] [PubMed] [Google Scholar]
  17. Blinkhorn R. J., Adelstein D., Spagnuolo P. J. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol. 1989 Feb;27(2):236–240. doi: 10.1128/jcm.27.2.236-240.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bodey G. P. What's new in fungal infection in leukemic patients. Leuk Lymphoma. 1993;11 (Suppl 2):127–135. doi: 10.3109/10428199309064272. [DOI] [PubMed] [Google Scholar]
  19. Booth L. V., Collins A. L., Lowes J. A., Radford M. Skin rash associated with Candida guilliermondii. Med Pediatr Oncol. 1988;16(4):295–296. doi: 10.1002/mpo.2950160417. [DOI] [PubMed] [Google Scholar]
  20. Borg-von Zepelin M., Eiffert H., Kann M., Rüchel R. Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Göttingen, Germany. Mycoses. 1993 Jul-Aug;36(7-8):247–253. doi: 10.1111/j.1439-0507.1993.tb00759.x. [DOI] [PubMed] [Google Scholar]
  21. Bougnoux M. E., Gueho E., Potocka A. C. Resolutive Candida utilis fungemia in a nonneutropenic patient. J Clin Microbiol. 1993 Jun;31(6):1644–1645. doi: 10.1128/jcm.31.6.1644-1645.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Brajtburg J., Powderly W. G., Kobayashi G. S., Medoff G. Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother. 1990 Feb;34(2):183–188. doi: 10.1128/aac.34.2.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Branchini M. L., Pfaller M. A., Rhine-Chalberg J., Frempong T., Isenberg H. D. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol. 1994 Feb;32(2):452–456. doi: 10.1128/jcm.32.2.452-456.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Braun D. K., Kauffman C. A. Rhodotorula fungaemia: a life-threatening complication of indwelling central venous catheters. Mycoses. 1992 Nov-Dec;35(11-12):305–308. doi: 10.1111/j.1439-0507.1992.tb00882.x. [DOI] [PubMed] [Google Scholar]
  25. Carmody T. J., Kane K. K. Torulopsis (Candida) glabrata endocarditis involving a bovine pericardial xenograft heart valve. Heart Lung. 1986 Jan;15(1):40–42. [PubMed] [Google Scholar]
  26. Chakrabarti A., Chander J., Kasturi P., Panigrahi D. Candidaemia: a 10-year study in an Indian teaching hospital. Mycoses. 1992 Jan-Feb;35(1-2):47–51. doi: 10.1111/j.1439-0507.1992.tb00818.x. [DOI] [PubMed] [Google Scholar]
  27. Chertow G. M., Marcantonio E. R., Wells R. G. Saccharomyces cerevisiae empyema in a patient with esophago-pleural fistula complicating variceal sclerotherapy. Chest. 1991 Jun;99(6):1518–1519. doi: 10.1378/chest.99.6.1518. [DOI] [PubMed] [Google Scholar]
  28. Cimolai N., Gill M. J., Church D. Saccharomyces cerevisiae fungemia: case report and review of the literature. Diagn Microbiol Infect Dis. 1987 Oct;8(2):113–117. doi: 10.1016/0732-8893(87)90158-1. [DOI] [PubMed] [Google Scholar]
  29. Crozier W. J. Two cases of onychomycosis due to Candida zeylanoides. Australas J Dermatol. 1993;34(1):23–25. doi: 10.1111/j.1440-0960.1993.tb00842.x. [DOI] [PubMed] [Google Scholar]
  30. D'Antonio D., Fioritoni G., Iacone A., Betti S., Fazii P., Dell'Isola M., Di Gianfilippo R., Di Silverio A., Ubezio S., Zeccara C. Hepatosplenic infection caused by Candida parapsilosis in patients with acute leukemia. Mycoses. 1992 Nov-Dec;35(11-12):311–313. doi: 10.1111/j.1439-0507.1992.tb00884.x. [DOI] [PubMed] [Google Scholar]
  31. D'Antonio D., Piccolomini R., Fioritoni G., Iacone A., Betti S., Fazii P., Mazzoni A. Osteomyelitis and intervertebral discitis caused by Blastoschizomyces capitatus in a patient with acute leukemia. J Clin Microbiol. 1994 Jan;32(1):224–227. doi: 10.1128/jcm.32.1.224-227.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Dick J. D., Rosengard B. R., Merz W. G., Stuart R. K., Hutchins G. M., Saral R. Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. Ann Intern Med. 1985 Jan;102(1):67–68. doi: 10.7326/0003-4819-102-1-67. [DOI] [PubMed] [Google Scholar]
  33. Dickensheets D. L. Hansenula anomala infection. Rev Infect Dis. 1989 May-Jun;11(3):507–508. doi: 10.1093/clinids/11.3.507. [DOI] [PubMed] [Google Scholar]
  34. Dubé M. P., Heseltine P. N., Rinaldi M. G., Evans S., Zawacki B. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis. 1994 Jan;18(1):77–82. doi: 10.1093/clinids/18.1.77. [DOI] [PubMed] [Google Scholar]
  35. Dyess D. L., Garrison R. N., Fry D. E. Candida sepsis. Implications of polymicrobial blood-borne infection. Arch Surg. 1985 Mar;120(3):345–348. doi: 10.1001/archsurg.1985.01390270083014. [DOI] [PubMed] [Google Scholar]
  36. Eisenberg E. S., Alpert B. E., Weiss R. A., Mittman N., Soeiro R. Rhodotorula rubra peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Am J Med. 1983 Aug;75(2):349–352. doi: 10.1016/0002-9343(83)91216-0. [DOI] [PubMed] [Google Scholar]
  37. Eisenberg E. S., Leviton I., Soeiro R. Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature. Rev Infect Dis. 1986 May-Jun;8(3):309–321. doi: 10.1093/clinids/8.3.309. [DOI] [PubMed] [Google Scholar]
  38. Eng R. H., Drehmel R., Smith S. M., Goldstein E. J. Saccharomyces cerevisiae infections in man. Sabouraudia. 1984;22(5):403–407. [PubMed] [Google Scholar]
  39. Fisher D. J., Christy C., Spafford P., Maniscalco W. M., Hardy D. J., Graman P. S. Neonatal Trichosporon beigelii infection: report of a cluster of cases in a neonatal intensive care unit. Pediatr Infect Dis J. 1993 Feb;12(2):149–155. [PubMed] [Google Scholar]
  40. Furman R. M., Ahearn D. G. Candida ciferrii and Candida chiropterorum isolated from clinical specimens. J Clin Microbiol. 1983 Nov;18(5):1252–1255. doi: 10.1128/jcm.18.5.1252-1255.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Gabal M. A. Antifungal activity of ketoconazole with emphasis on zoophilic fungal pathogens. Am J Vet Res. 1986 Jun;47(6):1229–1234. [PubMed] [Google Scholar]
  42. Gargeya I. B., Pruitt W. R., Meyer S. A., Ahearn D. G. Candida haemulonii from clinical specimens in the USA. J Med Vet Mycol. 1991;29(5):335–338. [PubMed] [Google Scholar]
  43. Gelfand M. S. Candida tropicalis. Infect Control Hosp Epidemiol. 1989 Jun;10(6):280–283. doi: 10.1086/646024. [DOI] [PubMed] [Google Scholar]
  44. Glick C., Graves G. R., Feldman S. Torulopsis glabrata in the neonate: an emerging fungal pathogen. South Med J. 1993 Aug;86(8):969–970. doi: 10.1097/00007611-199308000-00026. [DOI] [PubMed] [Google Scholar]
  45. Gold W. L., Vellend H., Salit I. E., Campbell I., Summerbell R., Rinaldi M., Simor A. E. Successful treatment of systemic and local infections due to Exophiala species. Clin Infect Dis. 1994 Aug;19(2):339–341. doi: 10.1093/clinids/19.2.339. [DOI] [PubMed] [Google Scholar]
  46. Goldman M., Pottage J. C., Jr, Weaver D. C. Candida krusei fungemia. Report of 4 cases and review of the literature. Medicine (Baltimore) 1993 May;72(3):143–150. [PubMed] [Google Scholar]
  47. Gugnani H. C., Okafor B. C., Nzelibe F., Njoku-Obi A. N. Etiological agents of otomycosis in Nigeria. Mycoses. 1989 May;32(5):224–229. doi: 10.1111/j.1439-0507.1989.tb02236.x. [DOI] [PubMed] [Google Scholar]
  48. Guého E., Improvisi L., de Hoog G. S., Dupont B. Trichosporon on humans: a practical account. Mycoses. 1994 Jan-Feb;37(1-2):3–10. doi: 10.1111/j.1439-0507.1994.tb00277.x. [DOI] [PubMed] [Google Scholar]
  49. Hadfield T. L., Smith M. B., Winn R. E., Rinaldi M. G., Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis. 1987 Sep-Oct;9(5):1006–1012. doi: 10.1093/clinids/9.5.1006. [DOI] [PubMed] [Google Scholar]
  50. Hamilton-Miller J. M. The effect of pH and of temperature on the stability and bioactivity of nystatin and amphotericin B. J Pharm Pharmacol. 1973 May;25(5):401–407. doi: 10.1111/j.2042-7158.1973.tb10035.x. [DOI] [PubMed] [Google Scholar]
  51. Haron E., Anaissie E., Dumphy F., McCredie K., Fainstein V. Hansenula anomala fungemia. Rev Infect Dis. 1988 Nov-Dec;10(6):1182–1186. doi: 10.1093/clinids/10.6.1182. [DOI] [PubMed] [Google Scholar]
  52. Hector R. F. Compounds active against cell walls of medically important fungi. Clin Microbiol Rev. 1993 Jan;6(1):1–21. doi: 10.1128/cmr.6.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Heinic G. S., Greenspan D., MacPhail L. A., Greenspan J. S. Oral Geotrichum candidum infection associated with HIV infection. A case report. Oral Surg Oral Med Oral Pathol. 1992 Jun;73(6):726–728. doi: 10.1016/0030-4220(92)90019-m. [DOI] [PubMed] [Google Scholar]
  54. Heney C., Greeff M., Davis V. Hickman catheter-related protothecal algaemia in an immunocompromised child. J Infect Dis. 1991 Apr;163(4):930–931. doi: 10.1093/infdis/163.4.930. [DOI] [PubMed] [Google Scholar]
  55. Hilmarsdottir I., Coutellier A., Elbaz J., Klein J. M., Datry A., Guého E., Herson S. A French case of laboratory-acquired disseminated Penicillium marneffei infection in a patient with AIDS. Clin Infect Dis. 1994 Aug;19(2):357–358. doi: 10.1093/clinids/19.2.357. [DOI] [PubMed] [Google Scholar]
  56. Hirasaki S., Ijichi T., Fujita N., Araki S., Gotoh H., Nakagawa M. Fungemia caused by Hansenula anomala: successful treatment with fluconazole. Intern Med. 1992 May;31(5):622–624. doi: 10.2169/internalmedicine.31.622. [DOI] [PubMed] [Google Scholar]
  57. Hiruma M., Kawada A., Ohata H., Ohnishi Y., Takahashi H., Yamazaki M., Ishibashi A., Hatsuse K., Kakihara M., Yoshida M. Systemic phaeohyphomycosis caused by Exophiala dermatitidis. Mycoses. 1993 Jan-Feb;36(1-2):1–7. doi: 10.1111/j.1439-0507.1993.tb00679.x. [DOI] [PubMed] [Google Scholar]
  58. Horn R., Wong B., Kiehn T. E., Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis. 1985 Sep-Oct;7(5):646–655. doi: 10.1093/clinids/7.5.646. [DOI] [PubMed] [Google Scholar]
  59. Kaminski Z. C., Kapila R., Sharer L. R., Kloser P., Kaufman L. Meningitis due to Prototheca wickerhamii in a patient with AIDS. Clin Infect Dis. 1992 Oct;15(4):704–706. doi: 10.1093/clind/15.4.704. [DOI] [PubMed] [Google Scholar]
  60. Karabinis A., Hill C., Leclercq B., Tancrède C., Baume D., Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol. 1988 Mar;26(3):429–432. doi: 10.1128/jcm.26.3.429-432.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Katzenstein D. Isolated Candida arthritis: report of a case and definition of a distinct clinical syndrome. Arthritis Rheum. 1985 Dec;28(12):1421–1424. doi: 10.1002/art.1780281216. [DOI] [PubMed] [Google Scholar]
  62. Kiehn T. E., Gorey E., Brown A. E., Edwards F. F., Armstrong D. Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clin Infect Dis. 1992 Apr;14(4):841–846. doi: 10.1093/clinids/14.4.841. [DOI] [PubMed] [Google Scholar]
  63. Klein A. S., Tortora G. T., Malowitz R., Greene W. H. Hansenula anomala: a new fungal pathogen. Two case reports and a review of the literature. Arch Intern Med. 1988 May;148(5):1210–1213. doi: 10.1001/archinte.148.5.1210. [DOI] [PubMed] [Google Scholar]
  64. Klotz S. A. Malassezia furfur. Infect Dis Clin North Am. 1989 Mar;3(1):53–64. [PubMed] [Google Scholar]
  65. Komshian S. V., Uwaydah A. K., Sobel J. D., Crane L. R. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis. 1989 May-Jun;11(3):379–390. doi: 10.1093/clinids/11.3.379. [DOI] [PubMed] [Google Scholar]
  66. Krogh P., Holmstrup P., Thorn J. J., Vedtofte P., Pindborg J. J. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol. 1987 Jan;63(1):48–54. doi: 10.1016/0030-4220(87)90339-2. [DOI] [PubMed] [Google Scholar]
  67. Lehmann P. F., Wu L. C., Pruitt W. R., Meyer S. A., Ahearn D. G. Unrelatedness of groups of yeasts within the Candida haemulonii complex. J Clin Microbiol. 1993 Jul;31(7):1683–1687. doi: 10.1128/jcm.31.7.1683-1687.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Levenson D., Pfaller M. A., Smith M. A., Hollis R., Gerarden T., Tucci C. B., Isenberg H. D. Candida zeylanoides: another opportunistic yeast. J Clin Microbiol. 1991 Aug;29(8):1689–1692. doi: 10.1128/jcm.29.8.1689-1692.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Manian F. A., Brischetto M. J. Pulmonary infection due to Exophiala jeanselmei: successful treatment with ketoconazole. Clin Infect Dis. 1993 Mar;16(3):445–446. doi: 10.1093/clind/16.3.445. [DOI] [PubMed] [Google Scholar]
  70. Marcon M. J., Powell D. A. Human infections due to Malassezia spp. Clin Microbiol Rev. 1992 Apr;5(2):101–119. doi: 10.1128/cmr.5.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Martino P., Venditti M., Micozzi A., Morace G., Polonelli L., Mantovani M. P., Petti M. C., Burgio V. L., Santini C., Serra P. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis. 1990 Jul-Aug;12(4):570–582. doi: 10.1093/clinids/12.4.570. [DOI] [PubMed] [Google Scholar]
  72. Martín E., Parras P., Lozano M. C. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole. Chemotherapy. 1992;38(5):335–339. doi: 10.1159/000239023. [DOI] [PubMed] [Google Scholar]
  73. McGinnis M. R., Ajello L., Beneke E. S., Drouhet E., Goodman N. L., Halde C. J., Haley L. D., Kane J., Land G. A., Padhye A. A. Taxonomic and nomenclatural evaluation of the genera Candida and Torulopsis. J Clin Microbiol. 1984 Oct;20(4):813–814. doi: 10.1128/jcm.20.4.813-814.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Medoff G., Brajtburg J., Kobayashi G. S., Bolard J. Antifungal agents useful in therapy of systemic fungal infections. Annu Rev Pharmacol Toxicol. 1983;23:303–330. doi: 10.1146/annurev.pa.23.040183.001511. [DOI] [PubMed] [Google Scholar]
  75. Merz W. G. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol. 1984 Dec;20(6):1194–1195. doi: 10.1128/jcm.20.6.1194-1195.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Meunier F., Aoun M., Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S120–S125. doi: 10.1093/clinids/14.supplement_1.s120. [DOI] [PubMed] [Google Scholar]
  77. Middelhoven W. J., De Kievit H., Biesbroek A. L. Yeast species utilizing uric acid, adenine, n-alkylamines or diamines as sole source of carbon and energy. Antonie Van Leeuwenhoek. 1985;51(3):289–301. doi: 10.1007/BF02439938. [DOI] [PubMed] [Google Scholar]
  78. Mirza S. H. Disseminated Trichosporon beigelii infection causing skin lesions in a renal transplant patient. J Infect. 1993 Jul;27(1):67–70. doi: 10.1016/0163-4453(93)93838-u. [DOI] [PubMed] [Google Scholar]
  79. Molina T. C., Mishra S. K., Pierson D. L. A microfermentation test for the rapid identification of yeasts. J Med Vet Mycol. 1992;30(4):323–326. doi: 10.1080/02681219280000421. [DOI] [PubMed] [Google Scholar]
  80. Morgan M. A., Wilkowske C. J., Roberts G. D. Candida pseudotropicalis fungemia and invasive disease in an immunocompromised patient. J Clin Microbiol. 1984 Nov;20(5):1006–1007. doi: 10.1128/jcm.20.5.1006-1007.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Morris J. T., Beckius M., McAllister C. K. Sporobolomyces infection in an AIDS patient. J Infect Dis. 1991 Sep;164(3):623–624. doi: 10.1093/infdis/164.3.623. [DOI] [PubMed] [Google Scholar]
  82. Morris J. T., McAllister C. K. Fungemia due to Torulopsis glabrata. South Med J. 1993 Mar;86(3):356–357. doi: 10.1097/00007611-199303000-00021. [DOI] [PubMed] [Google Scholar]
  83. Morrison A. J., Jr, Freer C. V., Searcy M. A., Landry S. M., Wenzel R. P. Nosocomial bloodstream infections: secular trends in a statewide surveillance program in Virginia. Infect Control. 1986 Nov;7(11):550–553. doi: 10.1017/s0195941700065309. [DOI] [PubMed] [Google Scholar]
  84. Murphy N., Buchanan C. R., Damjanovic V., Whitaker R., Hart C. A., Cooke R. W. Infection and colonisation of neonates by Hansenula anomala. Lancet. 1986 Feb 8;1(8476):291–293. doi: 10.1016/s0140-6736(86)90827-5. [DOI] [PubMed] [Google Scholar]
  85. Muñoz P., Garcia Leoni M. E., Berenguer J., Bernaldo de Quiros J. C., Bouza E. Catheter-related fungemia by Hansenula anomala. Arch Intern Med. 1989 Mar;149(3):709–713. doi: 10.1001/archinte.1989.00390030151034. [DOI] [PubMed] [Google Scholar]
  86. Neumeister B., Rockemann M., Marre R. Fungaemia due to Candida pelliculosa in a case of acute pancreatitis. Mycoses. 1992 Nov-Dec;35(11-12):309–310. doi: 10.1111/j.1439-0507.1992.tb00883.x. [DOI] [PubMed] [Google Scholar]
  87. Nielsen H., Stenderup J., Bruun B., Ladefoged J. Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1990 Jul;28(7):1664–1665. doi: 10.1128/jcm.28.7.1664-1665.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Nohinek B., Zee-Cheng C. S., Barnes W. G., Dall L., Gibbs H. R. Infective endocarditis of a bicuspid aortic valve caused by Hansenula anomala. Am J Med. 1987 Jan;82(1):165–168. doi: 10.1016/0002-9343(87)90400-1. [DOI] [PubMed] [Google Scholar]
  89. Oriol A., Ribera J. M., Arnal J., Milla F., Batlle M., Feliu E. Saccharomyces cerevisiae septicemia in a patient with myelodysplastic syndrome. Am J Hematol. 1993 Aug;43(4):325–326. doi: 10.1002/ajh.2830430424. [DOI] [PubMed] [Google Scholar]
  90. Pappagianis D., Collins M. S., Hector R., Remington J. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother. 1979 Aug;16(2):123–126. doi: 10.1128/aac.16.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Pautler K. B., Padhye A. A., Ajello L. Imported penicilliosis marneffei in the United States: report of a second human infection. Sabouraudia. 1984;22(5):433–438. doi: 10.1080/00362178485380691. [DOI] [PubMed] [Google Scholar]
  92. Pfaller M. A., Barry A. L. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol. 1994 Aug;32(8):1992–1996. doi: 10.1128/jcm.32.8.1992-1996.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Pfaller M. A. Infection control: opportunistic fungal infections--the increasing importance of Candida species. Infect Control Hosp Epidemiol. 1989 Jun;10(6):270–273. doi: 10.1086/646021. [DOI] [PubMed] [Google Scholar]
  94. Plazas J., Portilla J., Boix V., Pérez-Mateo M. Sporobolomyces salmonicolor lymphadenitis in an AIDS patient. Pathogen or passenger? AIDS. 1994 Mar;8(3):387–388. doi: 10.1097/00002030-199403000-00015. [DOI] [PubMed] [Google Scholar]
  95. Polacheck I., Salkin I. F., Kitzes-Cohen R., Raz R. Endocarditis caused by Blastoschizomyces capitatus and taxonomic review of the genus. J Clin Microbiol. 1992 Sep;30(9):2318–2322. doi: 10.1128/jcm.30.9.2318-2322.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Pospisil L. The significance of Candida pulcherrima findings in human clinical specimens. Mycoses. 1989 Nov;32(11):581–583. [PubMed] [Google Scholar]
  97. Price M. F., LaRocco M. T., Gentry L. O. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother. 1994 Jun;38(6):1422–1424. doi: 10.1128/aac.38.6.1422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Rao N. A., Nerenberg A. V., Forster D. J. Torulopsis candida (Candida famata) endophthalmitis simulating Propionibacterium acnes syndrome. Arch Ophthalmol. 1991 Dec;109(12):1718–1721. doi: 10.1001/archopht.1991.01080120102037. [DOI] [PubMed] [Google Scholar]
  99. Regli P., Blancard A., Goudard M., Moulin-Traffort J., Sarzier J. M., Quilici M. Evaluation de la sensibilité in vitro au fluconazole de différentes espèces de levures rencontrées en pathologie. Pathol Biol (Paris) 1992 May;40(5):500–506. [PubMed] [Google Scholar]
  100. Reinhardt J. F., Ruane P. J., Walker L. J., George W. L. Intravenous catheter-associated fungemia due to Candida rugosa. J Clin Microbiol. 1985 Dec;22(6):1056–1057. doi: 10.1128/jcm.22.6.1056-1057.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Rex J. H., Bennett J. E., Sugar A. M., Pappas P. G., van der Horst C. M., Edwards J. E., Washburn R. G., Scheld W. M., Karchmer A. W., Dine A. P. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med. 1994 Nov 17;331(20):1325–1330. doi: 10.1056/NEJM199411173312001. [DOI] [PubMed] [Google Scholar]
  102. Rex J. H., Pfaller M. A., Barry A. L., Nelson P. W., Webb C. D. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Antimicrob Agents Chemother. 1995 Jan;39(1):40–44. doi: 10.1128/aac.39.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Richet H. M., Andremont A., Tancrede C., Pico J. L., Jarvis W. R. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis. 1991 Mar-Apr;13(2):211–215. doi: 10.1093/clinids/13.2.211. [DOI] [PubMed] [Google Scholar]
  104. Rinaldi M. G. Emerging opportunists. Infect Dis Clin North Am. 1989 Mar;3(1):65–76. [PubMed] [Google Scholar]
  105. Salesa R., Burgos A., Fernandez-Mazarrasa C., Quindós G., Pontón J. Transient fungaemia due to Candida pelliculosa in a patient with AIDS. Mycoses. 1991 Jul-Aug;34(7-8):327–329. doi: 10.1111/j.1439-0507.1991.tb00670.x. [DOI] [PubMed] [Google Scholar]
  106. Samonis G., Bafaloukos D. Fungal infections in cancer patients: an escalating problem. In Vivo. 1992 Mar-Apr;6(2):183–193. [PubMed] [Google Scholar]
  107. Sanchez V., Vazquez J. A., Barth-Jones D., Dembry L., Sobel J. D., Zervos M. J. Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol. 1992 Nov;30(11):3005–3008. doi: 10.1128/jcm.30.11.3005-3008.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Sanchez V., Vazquez J. A., Barth-Jones D., Dembry L., Sobel J. D., Zervos M. J. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med. 1993 Jun;94(6):577–582. doi: 10.1016/0002-9343(93)90207-6. [DOI] [PubMed] [Google Scholar]
  109. Sandhu D. K., Sandhu R. S., Misra V. C. Isolation of Candida viswanathii from cerebrospinal fluid. Sabouraudia. 1976 Nov;14(3):251–254. [PubMed] [Google Scholar]
  110. Sands M., Poppel D., Brown R. Peritonitis due to Prototheca wickerhamii in a patient undergoing chronic ambulatory peritoneal dialysis. Rev Infect Dis. 1991 May-Jun;13(3):376–378. doi: 10.1093/clinids/13.3.376. [DOI] [PubMed] [Google Scholar]
  111. Seidenfeld S. M., Cooper B. H., Smith J. W., Luby J. P., Mackowiak P. A. Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species. J Infect Dis. 1983 Jan;147(1):116–119. doi: 10.1093/infdis/147.1.116. [DOI] [PubMed] [Google Scholar]
  112. Sethi N., Mandell W. Saccharomyces fungemia in a patient with AIDS. N Y State J Med. 1988 May;88(5):278–279. [PubMed] [Google Scholar]
  113. Sinnott J. T., 4th, Cullison J. P., Sweeney M. P. Candida (Torulopsis) glabrata. Infect Control. 1987 Aug;8(8):334–336. doi: 10.1017/s0195941700066443. [DOI] [PubMed] [Google Scholar]
  114. Sobel J. D., Vazquez J., Lynch M., Meriwether C., Zervos M. J. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy. Clin Infect Dis. 1993 Jan;16(1):93–99. doi: 10.1093/clinids/16.1.93. [DOI] [PubMed] [Google Scholar]
  115. Solomon S. L., Khabbaz R. F., Parker R. H., Anderson R. L., Geraghty M. A., Furman R. M., Martone W. J. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis. 1984 Jan;149(1):98–102. doi: 10.1093/infdis/149.1.98. [DOI] [PubMed] [Google Scholar]
  116. St-Germain G., Laverdière M. Torulopsis candida, a new opportunistic pathogen. J Clin Microbiol. 1986 Nov;24(5):884–885. doi: 10.1128/jcm.24.5.884-885.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. States B., Segal S. Levels of gamma-glutamyltranspeptidase in cultured skin fibroblasts from cystinotics and normals. Life Sci. 1980 Nov 24;27(21):1985–1990. doi: 10.1016/0024-3205(80)90419-1. [DOI] [PubMed] [Google Scholar]
  118. Stellbrink H. J., Albrecht H., Fenske S., Koperski K. Candida krusei sepsis in HIV infection. AIDS. 1992 Jul;6(7):746–748. doi: 10.1097/00002030-199207000-00025. [DOI] [PubMed] [Google Scholar]
  119. Strausbaugh L. J., Sewell D. L., Ward T. T., Pfaller M. A., Heitzman T., Tjoelker R. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol. 1994 Sep;32(9):2299–2300. doi: 10.1128/jcm.32.9.2299-2300.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Sudduth E. J., Crumbley A. J., 3rd, Farrar W. E. Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans. Clin Infect Dis. 1992 Oct;15(4):639–644. doi: 10.1093/clind/15.4.639. [DOI] [PubMed] [Google Scholar]
  121. Sugar A. M., Stevens D. A. Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literature. Cancer. 1985 Jul 15;56(2):318–320. doi: 10.1002/1097-0142(19850715)56:2<318::aid-cncr2820560219>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  122. Supparatpinyo K., Chiewchanvit S., Hirunsri P., Uthammachai C., Nelson K. E., Sirisanthana T. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992 Apr;14(4):871–874. doi: 10.1093/clinids/14.4.871. [DOI] [PubMed] [Google Scholar]
  123. Supparatpinyo K., Sirisanthana T. Disseminated Penicillium marneffei infection diagnosed on examination of a peripheral blood smear of a patient with human immunodeficiency virus infection. Clin Infect Dis. 1994 Feb;18(2):246–247. doi: 10.1093/clinids/18.2.246. [DOI] [PubMed] [Google Scholar]
  124. Takamiya H., Vogt A., Batsford S., Kuttin E. S., Müller J. Further studies on the immunoelectronmicroscopic localization of polysaccharide antigens on ultra-thin sections of Candida albicans. Mykosen. 1985 Jan;28(1):17–32. doi: 10.1111/j.1439-0507.1985.tb02069.x. [DOI] [PubMed] [Google Scholar]
  125. Teglia O., Schoch P. E., Cunha B. A. Malassezia furfur infections. Infect Control Hosp Epidemiol. 1991 Nov;12(11):676–681. doi: 10.1086/646265. [DOI] [PubMed] [Google Scholar]
  126. Ujhelyi M. R., Raasch R. H., van der Horst C. M., Mattern W. D. Treatment of peritonitis due to Curvularia and Trichosporon with amphotericin B. Rev Infect Dis. 1990 Jul-Aug;12(4):621–627. doi: 10.1093/clinids/12.4.621. [DOI] [PubMed] [Google Scholar]
  127. Walsh T. J., Melcher G. P., Lee J. W., Pizzo P. A. Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol. 1993;5:79–113. [PubMed] [Google Scholar]
  128. Walsh T. J., Melcher G. P., Rinaldi M. G., Lecciones J., McGough D. A., Kelly P., Lee J., Callender D., Rubin M., Pizzo P. A. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol. 1990 Jul;28(7):1616–1622. doi: 10.1128/jcm.28.7.1616-1622.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Walsh T. J., Salkin I. F., Dixon D. M., Hurd N. J. Clinical, microbiological, and experimental animal studies of Candida lipolytica. J Clin Microbiol. 1989 May;27(5):927–931. doi: 10.1128/jcm.27.5.927-931.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Walsh T. J. Trichosporonosis. Infect Dis Clin North Am. 1989 Mar;3(1):43–52. [PubMed] [Google Scholar]
  131. Weems J. J., Jr Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis. 1992 Mar;14(3):756–766. doi: 10.1093/clinids/14.3.756. [DOI] [PubMed] [Google Scholar]
  132. Wehrspann P., Füllbrandt U. Fallbericht über eine aus einer Blutkultur isolierte Yarrowia lipolytica (Wickerham et al.) van der Walt & von Arx. Mykosen. 1985 May;28(5):217–222. [PubMed] [Google Scholar]
  133. Wey S. B., Mori M., Pfaller M. A., Woolson R. F., Wenzel R. P. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med. 1988 Dec;148(12):2642–2645. doi: 10.1001/archinte.148.12.2642. [DOI] [PubMed] [Google Scholar]
  134. Wickerham L. J., Burton K. A. Carbon Assimilation Tests for the Classification of Yeasts. J Bacteriol. 1948 Sep;56(3):363–371. doi: 10.1128/jb.56.3.363-371.1948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Wickes B. L., Hicks J. B., Merz W. G., Kwon-Chung K. J. The molecular analysis of synonymy among medically important yeasts within the genus Candida. J Gen Microbiol. 1992 May;138(5):901–907. doi: 10.1099/00221287-138-5-901. [DOI] [PubMed] [Google Scholar]
  136. Wingard J. R., Merz W. G., Rinaldi M. G., Johnson T. R., Karp J. E., Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med. 1991 Oct 31;325(18):1274–1277. doi: 10.1056/NEJM199110313251803. [DOI] [PubMed] [Google Scholar]
  137. Yamaguchi H., Uchida K. [In vitro susceptibility to fluconazole of fungal strains freshly isolated from child patients with deep-seated mycoses]. Jpn J Antibiot. 1993 Aug;46(8):647–653. [PubMed] [Google Scholar]
  138. Yinnon A. M., Woodin K. A., Powell K. R. Candida lusitaniae infection in the newborn: case report and review of the literature. Pediatr Infect Dis J. 1992 Oct;11(10):878–880. doi: 10.1097/00006454-199210000-00014. [DOI] [PubMed] [Google Scholar]
  139. de Gentile L., Bouchara J. P., Cimon B., Chabasse D. Candida ciferrii: clinical and microbiological features of an emerging pathogen. Mycoses. 1991 Mar-Apr;34(3-4):125–128. doi: 10.1111/j.1439-0507.1991.tb00632.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES